PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Integra Therapeutics closes new EUR1.5m investment as Columbus Venture Partners joins seed round

Integra Therapeutics, a biotechnology company that creates next- generation gene writing tools, has closed an additional EUR1.5-million investment from venture capital firm Columbus Venture Partners. This investment comes on top of the EUR4.5 million Integra Therapeutics raised last December from AdBio Partners, Invivo Capital and Takeda Ventures and completes its seed round in line with the company’s set goals.

The new funds will go to support development of the FiCAT platform prototype and preclinical validation with in vivo and ex vivo models. 

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured